AsiaMedic EBIT per Share
EBIT per Share of AsiaMedic (505.SI) as of Nov 3, 2026.
Get this data via API
Financial Data API
EBIT per Share
0.00SGD
YoY
-4.08%
Last updated:
EBIT per Share of AsiaMedic is 2025 0.00 SGD. EBIT per Share of AsiaMedic was 2024 0.00 SGD. It decreases by -4.08% lower compared to the previous year.
The AsiaMedic EBIT per Share history
3 Years
10 Years
25 Years
Max
EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-0.00 SGD
Jan 1, 2019
-0.00 SGD
Jan 1, 2020
-0.00 SGD
Jan 1, 2021
0.00 SGD
Jan 1, 2022
0.00 SGD
Jan 1, 2023
0.00 SGD
Jan 1, 2024
0.00 SGD
Jan 1, 2025
0.00 SGD
| YEAR | EBIT per Share | YoY |
|---|---|---|
| 0.00SGD | -4.08% | |
| 0.00SGD | -12.60% | |
| 0.00SGD | -44.03% | |
| 0.00SGD | -42.17% | |
| 0.00SGD | -125.75% | |
| -0.00SGD | +41.97% | |
| -0.00SGD | -25.94% | |
| -0.00SGD | +5.00% | |
| -0.00SGD | +108.35% | |
| -0.00SGD | +8.32% | |
| -0.00SGD | +466.34% | |
| -0.00SGD | -43.46% | |
| -0.00SGD | +24.47% | |
| -0.00SGD | -74.13% | |
| -0.00SGD | +627.31% | |
| -0.00SGD | -111.11% | |
| 0.00SGD | -45.42% | |
| 0.00SGD | +18.45% | |
| 0.00SGD | +155.22% | |
| 0.00SGD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
AsiaMedic Stock analysis
What does AsiaMedic do? AsiaMedic Ltd generates revenue through its subsidiaries offering specialized healthcare services. The Orchard Imaging Centre Pte Ltd provides diagnostic imaging and radiology services, while AsiaMedic PET/CT Centre Pte Ltd and AsiaMedic Heart & Vascular Centre Pte Ltd also deliver diagnostic imaging and radiology services. AsiaMedic Wellness Assessment Centre Pte Ltd focuses on health screening and medical wellness services, and Complete Healthcare International Pte Ltd offers primary healthcare services. These services are provided to patients seeking medical diagnostics, wellness assessments, and primary care.
The company's revenue streams are derived from the management of these healthcare subsidiaries, which operate under their respective brand names. Customers include individuals requiring diagnostic imaging, health screenings, and primary healthcare services. The primary segments served are diagnostic imaging, wellness assessments, and primary healthcare, with each subsidiary targeting specific medical needs within these segments.
AsiaMedic Ltd's business model centers on managing multiple healthcare service providers under one holding company. The subsidiaries operate independently but share a common management structure, allowing for efficient resource allocation across diagnostic imaging, wellness, and primary care services. Revenue is generated through direct service provision to patients without third-party intermediaries. AsiaMedic is one of the most popular companies on Eulerpool.
Frequently Asked Questions about AsiaMedic stock
On Eulerpool you can find the complete historical development of EBIT per Share AsiaMedic since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — AsiaMedic
All Key Metrics — AsiaMedic
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth